Schwarzberg H, Kalbacher H, and Hoffmann W.
Differential behavioral effects of TFF peptides: injections of synthetic TFF3 into
the rat amygdala.
Pharmacol Biochem Behav. 1999 Jan;62(1):173-8 |
|
Wymann D, Bluggel M, Kalbacher H, Blesken T, Akdis CA, Meyer HE, and Blaser K.
Human B cells secrete migration inhibition factor (MIF) and present a naturally processed MIF peptide on HLA-DRB1*0405 by a FXXL motif.
Immunology. 1999 Jan;96(1):1-9 |
|
Antz C, Bauer T, Kalbacher H, Frank R, Covarrubias M, Kalbitzer HR, Ruppersberg JP, Baukrowitz T, and Fakler B.
Control of K+ channel gating by protein phosphorylation: structural switches of
the inactivation gate.
Nat Struct Biol. 1999 Feb;6(2):146-50 |
|
Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, and Gotz F.
Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides.
J Biol Chem. 1999 Mar 26;274(13):8405-10 |
|
Schroter CJ, Braun M, Englert J, Beck H, Schmid H, and Kalbacher H.
A rapid method to separate endosomes from lysosomal contents using
differential centrifugation and hypotonic lysis of lysosomes.
J Immunol Methods. 1999 Jul 30;227(1-2):161-8 |
|
Wissmann R, Baukrowitz T, Kalbacher H, Kalbitzer HR, Ruppersberg JP,
Pongs O, Antz C, and Fakler B.
NMR structure and functional characteristics of the hydrophilic N terminus of the potassium channel beta-subunit Kvbeta1.1.
J Biol Chem. 1999 Dec 10;274(50):35521-5
|
|
Lohmann T, Halder T, Engler J, Morgenthaler NG, Khoo-Morgenthaler UY, Schroder S, Seissler J, Scherbaum WA, and Kalbacher H.
T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes.
Exp Clin Endocrinol Diabetes. 1999;107(3):166-71 |
|
Wolpl A, Halder T, Kalbacher H, Neumeyer H, Siemoneit K, Goldmann SF,
and Eiermann TH.
Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells.
Tissue Antigens. 1998 Mar;51(3):258-69 |
|
Raulf-Heimsoth M, Chen Z, Rihs HP, Kalbacher H, Liebers V, and Baur X.
Analysis of T-cell reactive regions and HLA-DR4 binding motifs on the latex allergen Hev b 1 (rubber elongation factor).
Clin Exp Allergy. 1998 Mar;28(3):339-48 |
|
Boehncke WH, Loeliger C, Kuehnl P, Kalbacher H, Bohm BO, and Gall H.
Identification of HLA-DR and -DQ alleles conferring susceptibility to pollen allergy and pollen associated food allergy.
Clin Exp Allergy. 1998 Apr;28(4):434-41 |
|
Nenninger R, Schultz A, Hoffacker V, Helmreich M, Wilisch A,
Vandekerckhove B, Hunig T, Schalke B, Schneider C, Tzartos S, Kalbacher H, Muller-Hermelink HK, and Marx A.
Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas.
Lab Invest. 1998 Jun;78(6):743-53
|
|
Li K, Adibzadeh M, Halder T, Kalbacher H, Heinzel S, Muller C, Zeuthen J, and Pawelec G.
Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells.
Cancer Immunol Immunother. 1998 Sep;47(1):32-8 |
|
Flad T, Spengler B, Kalbacher H, Brossart P, Baier D, Kaufmann R, Bold P, Metzger S, Bluggel M, Meyer HE, Kurz B, and Muller CA.
Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method.
Cancer Res. 1998 Dec 15;58(24):5803-11 |
|
Boyton RJ, Lohmann T, Londei M, Kalbacher H, Halder T, Frater AJ,
Douek DC, Leslie DG, Flavell RA, and Altmann DM.
Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice.
Int Immunol. 1998 Dec;10(12):1765-76
|
|
Schmidlin A, Kalbacher H, and Wiesinger H.
Presence of argininosuccinate synthetase in glial cells as revealed by peptide-specific antisera.
Biol Chem. 1997 Jan;378(1):47-50 |
|
Padovan E, Bauer T, Tongio MM, Kalbacher H, and Weltzien HU.
Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy.
Eur J Immunol. 1997 Jun;27(6):1303-7 |
|
Curcio-Vonlanthen V, Schneider CH, Frutig K, Blaser K, and Kalbacher H.
Molecular parameters in melittin immunogenicity.
J Pept Sci. 1997 Jul-Aug;3(4):267-76 |
|
Halder T, Pawelec G, Kirkin AF, Zeuthen J, Meyer HE, Kun L, and
Kalbacher H.
Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3.
Cancer Res. 1997 Aug 1;57(15):3238-44
|
|
Vergelli M, Kalbus M, Rojo SC, Hemmer B, Kalbacher H, Tranquill L, Beck H, McFarland HF, De Mars R, Long EO, and Martin R.
T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
J Neuroimmunol. 1997 Aug;77(2):195-203 |
|
Stricker R, Kalbacher H, and Reiser G.
The epitope recognized by a monoclonal antibody in the myelin-associated protein CNP.
Biochem Biophys Res Commun. 1997 Aug 18;237(2):266-70 |
|
Griem P, Panthel K, Kalbacher H, and Gleichmann E.
Alteration of a model antigen by Au(III) leads to T cell sensitization to cryptic peptides.
Eur J Immunol. 1996 Feb;26(2):279-87 |
|
Muller CP, Ammerlaan W, Fleckenstein B, Krauss S, Kalbacher H, Schneider F, Jung G,
and Wiesmuller KH.
Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein.
Int Immunol. 1996 Apr;8(4):445-56
|
|
Beninga J, Kalbacher H, and Mach M.
Analysis of T helper cell response to glycoprotein H (gpUL75) of human cytomegalovirus: evidence for strain-specific T cell determinants.
J Infect Dis. 1996 May;173(5):1051-61 |
|
Fleckenstein B, Kalbacher H, Muller CP, Stoll D, Halder T, Jung G, and Wiesmuller KH.
New ligands binding to the human leukocyte antigen class II molecule DRB1*0101 based on the activity pattern of an undecapeptide library.
Eur J Biochem. 1996 Aug 15;240(1):71-7 |
|
Pawelec G, Max H, Halder T, Bruserud O, Merl A, da Silva P, and Kalbacher H.
BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells found at low frequency in the repertoire of normal donors.
Blood. 1996 Sep 15;88(6):2118-24 |
|
Pawelec G, Adibzadeh M, Bornhak S, Friccius H, Halder T, Kalbacher H, Li K, Max H, Muller C, Sansom D, Thiel F, and Zeuthen J.
The role of endogenous peptides in the direct pathway of alloreactivity to human MHC class II molecules expressed on CHO cells.
Immunol Rev. 1996 Dec;154:155-73 |
|
Griem P, Takahashi K, Kalbacher H, and Gleichmann E.
The antirheumatic drug disodium aurothiomalate inhibits CD4+ T cell recognition of peptides containing two or more cysteine residues.
J Immunol. 1995 Aug 1;155(3):1575-87 |
|
Pawelec G, Da Silva P, Max H, Kalbacher H, Schmidt H, Bruserud O, Zugel U, Baier W, Rehbein A, and Pohla H.
Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha.
Leuk Lymphoma. 1995 Aug;18(5-6):471-8 |
|
Stricker R, Kalbacher H, Lottspeich F, and Reiser G.
Characterization of a high-affinity Ins-P4 (inositol 1,3,4,5-tetrakisphosphate) receptor from brain by an anti-peptide antiserum.
FEBS Lett. 1995 Aug 21;370(3):236-40 |
|
Reiser G, Kunzelmann U, Hulser E, Stricker R, Hoppe J, Lottspeich F, and Kalbacher H.
Peptide-specific antibodies indicate species heterogeneity of a 42 kDa high-affinity inositol 1,3,4,5-tetrakisphosphate receptor protein from brain.
Biochem Biophys Res Commun. 1995 Sep 5;214(1):20-7 |
|